Now Available: Convalescent Plasma Support Kits for COVID-19 Response

On March 24th, the FDA announced it would consider case-by-case use of convalescent plasma for treatment of acute COVID-19 cases under the “process of single patient emergency Investigational New Drug Applications (eINDs) for Individual patients under 21 CFR 312.310.” This therapy is currently being tested for effectiveness in treating COVID-19, but has proven effective against similar viral outbreaks in the past.

Hospitals worldwide are looking to offer convalescent plasma to the sickest patients. With demand increasing every day and many critical cases time sensitive, using the typical blood donation pathway for convalescent plasma isn’t always possible. For hospitals whose laboratories can support the FDA-mandated testing to confirm donated plasma is safe, Drucker can provide key centrifugation tools.

The SERO 12 blood bank centrifuge is a drop in replacement for the BD SeroFuge™, a crucial component in blood typing and other testing steps to ensure compatibility of blood products prior to therapeutic use – a valuable tool even if convalescent plasma is being obtained via traditional plasma donation routes. The HORIZON 24 Flex plasma separation centrifuge spins up to 6x 50 mL blood tubes at 2000 xg in horizontal centrifugation, providing clean plasma ready for further preparation. The HORIZON 24 Flex can also help with your routine testing needs during the crisis: without switching rotors, this workhorse centrifuge can also spin 24 10 mL chemistry tubes.

These two powerful units are being offered in one simple kit. Both are lightweight and compact, easy to put on a benchtop and move as needed in the crowded, hectic lab of today. Both offer peace of mind with a two-year warranty and medical-grade safety certifications. Place an order directly with Drucker or through your preferred distributor to immediately request both of these valuable centrifuges.